<DOC>
	<DOCNO>NCT01650415</DOCNO>
	<brief_summary>This randomize placebo-controlled trial aim investigate efficacy safety erythropoetin child cerebral palsy .</brief_summary>
	<brief_title>Erythropoietin Therapy Children With Cerebral Palsy</brief_title>
	<detailed_description>Cerebral palsy disorder movement posture result nonprogressive lesion injury immature brain . It lead cause childhood onset disability . Many experimental animal study reveal erythropoietin useful repair neurological injury brain . The main mechanism erythropoietin suppose follow ; 1 . Neuroprotection effect 2 . Angiogenesis 3 . Anti-inflammation . On basis many experimental study , erythropoietin suggest therapeutic method cerebral palsy .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Cerebral Palsy Abnormal Muscle Tone Abnormal Brain MRI Willing Comply All Study Procedure Known Genetic Disorder Other Etiologies Contributing Developmental Delay Coagulopathy Initial high Erythropoietin level Serum Previous Erythropoietin Treatment 3 month Presence Drug Hypersensitivity Related Study Remedy Intractable Seizure Disorder Poor Cooperation Guardian include Inactive Attitude Rehabilitation</criteria>
	<gender>All</gender>
	<minimum_age>4 Months</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Cerebral Palsy</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>Rehabilitation</keyword>
</DOC>